NHIA_AnnualConference_24_White

Exhibitor Spotlight: B. Braun Medical Inc.

B. Braun Medical Inc.

Gold Member
FIAC

Can you share a brief summary of what your company does and how that fits into the home & alternate site infusion industry?

B. Braun Medical Inc. (B. Braun) is a leader in safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers and patients constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on their patients and to allow patients to treat themselves at home- we’re uniquely positioned to support patients’ needs wherever they are being treated now and in the future. To learn more about B. Braun Medical, visit bbraunusa.com.

What are you most looking forward to at NHIA 2023 in Washington, D.C.?

As leaders in cutting edge, automated compounding technology, we are looking forward to the opportunity to support the Parenteral Nutrition Sterile Compounding Clinic and share our expertise regarding compounding best practices.

What are the biggest challenges your customers are currently facing?

The biggest challenges our customers are facing are drug and labor shortages and increasing costs which make it difficult to care for their patients.

What are you most excited to share with attendees at the conference?

B. Braun Medical is excited to showcase our new line of Clik-FIX Catheter Securement Devices at NHIA. Clik-FIX was created with patient care in mind. It is designed to be comfortable and easy to use. All Clik-FIX securement devices are designed with skin-friendly adhesive and a padded foam cushion to maximize patient comfort and help reduce the risk of pressure injuries from the catheter hub.

Share:

Related Posts

Speaker Spotlight: Alisa Thomas

Hospital at Home Lessons Learned from a Large Integrated Health System! Join me as we discuss lessons learned from the last year of Hospital at Home services provided across the state of Utah and to over 1,000 patients.

Read More »